Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 10th, 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / March 3, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release...
Month: March 2022
Can B Corp. Executes Joint Venture with PrimeX Making its CBD Products Available in Brazil
Enabling Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million ConsumersHICKSVILLE, NY / ACCESSWIRE /...
Love Hemp Group PLC Announces Love Hemp Scoops Awards for its CBD Products
Love Hemp a Winner in this Year's Beauty Shortlist AwardsLONDON, UK / ACCESSWIRE / March 3, 2022 / Love Hemp...
Spexis Achieves First CARB-X Milestone for its Thanatin Derivatives Program and Receives Funding of up to USD 1.9 Million to Initiate Lead Optimization
ALLSCHWIL, SWITZERLAND / ACCESSWIRE / March 3, 2022 / Spexis AG (SIX:SPEX) announced today that it has been awarded the...
Aytu BioPharma Announces Pricing of $7.6 Million Registered Offering
ENGLEWOOD, CO / ACCESSWIRE / March 2, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
Therapy Retreats, like STAR Foundation’s 10-Day Program, Have Offered a Heart-Centered Healing Approach to People From All Over the World for More Than Forty Years
Star Foundation's Therapy Retreat Is Renowned for Delivering a Transformational Experience That Is Highly Tailored to Each IndividualTUBAC, AZ /...
Leveljump Healthcare Corp. Provides Updates on Telehospital Purchase; $2.5 Million Private Placement
Toronto, Ontario--(Newsfile Corp. - March 2, 2022) - LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the...
C3 AI Announces Fiscal Third Quarter 2022 Financial Results
Revenue Growth of 42% year over year to $69.8 million Raises Guidance to Reflect FY 2022 Revenue Growth of 38%...
Digital Health Companies Orbita and OnCall Health Choose Lyniate for Reliable Interoperability
Increased Customer Demand Fueled by Pandemic and Market Forces BOSTON--(BUSINESS WIRE)--Lyniate, a global leader in healthcare data interoperability, continued to...
Hemostemix Announces $2,750,000 Convertible Debenture
Calgary, Alberta--(Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...
MediFind Establishes Medical Advisory Board Led by Dr. Kyle Hogarth of University of Chicago Medicine to Further Advance Development of Consumer-Centric Health Platform
PHILADELPHIA--(BUSINESS WIRE)--MediFind, a consumer-centric health technology company that uses advanced analytics to connect patients with leading health experts, today announced...
Scientific Industries Secures New Funding to Accelerate Growth of Its Bioprocessing Business
BOHEMIA, NY / ACCESSWIRE / March 2, 2022 / Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a...
Emergent Health Subsidiary PharmaZu Executes Agreement with DynaCord to Develop Various Injectable and Topical Biologic Exosomes for the Treatment of Arthritis, Joint Care, Wound Care, and Inflammation for Pets
KING OF PRUSSIA, PA / ACCESSWIRE / March 2, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces subsidiary PharmaZu executes...
Aytu BioPharma Announces AR101 Granted Orphan Designation in Europe for the Treatment of Ehlers-Danlos Syndrome
ENGLEWOOD, CO / ACCESSWIRE / March 2, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
9 Meters Biopharma Announces a Collaboration with NYU Langone Health Investigating NM-102 as a Potential Treatment for an Autoimmune Disorder
RALEIGH, NC / ACCESSWIRE / March 2, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
Moderna to Present at Upcoming Conferences in March 2022
CAMBRIDGE, MA / ACCESSWIRE / March 2, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Celcuity to Participate in the Cowen 42nd Annual Health Care Conference
MINNEAPOLIS, MN / ACCESSWIRE / March 2, 2022 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing an integrated therapeutic...
Panacea Life Sciences, Inc. Expands Premium Skincare Line with Two New, Purpose-Driven CBD and CBG Products
GOLDEN, CO / ACCESSWIRE / March 2, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a Colorado, USA-based biotech...
SPO Global Inc. Announces Strategic Cooperation Plan
Shandong, China, March 02, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today...
HealthEquity Named One of the Nation’s Top Workplaces
Receives recognition after employees give HealthEquity high marks in national independent surveyDRAPER, Utah, March 02, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”),...